• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Med . Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank

tetano

Editor, Senior Moderator
BMC Med


. 2020 Nov 10;18(1):355.
doi: 10.1186/s12916-020-01822-4.
Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank


Fanny Petermann-Rocha[SUP] 1 2 [/SUP], Peter Hanlon[SUP] 1 [/SUP], Stuart R Gray[SUP] 2 [/SUP], Paul Welsh[SUP] 2 [/SUP], Jason M R Gill[SUP] 1 [/SUP], Hamish Foster[SUP] 1 [/SUP], S Vittal Katikireddi[SUP] 1 [/SUP], Donald Lyall[SUP] 1 [/SUP], Daniel F Mackay[SUP] 1 [/SUP], Catherine A O'Donnell[SUP] 1 [/SUP], Naveed Sattar[SUP] 2 [/SUP], Barbara I Nicholl[SUP] 1 [/SUP], Jill P Pell[SUP] 1 [/SUP], Bhautesh D Jani[SUP] 1 [/SUP], Frederick K Ho[SUP] 1 [/SUP], Frances S Mair[SUP] 1 [/SUP], Carlos Celis-Morales[SUP] 3 4 5 6 [/SUP]



Affiliations

Abstract

Background: Frailty has been associated with worse prognosis following COVID-19 infection. While several studies have reported the association between frailty and COVID-19 mortality or length of hospital stay, there have been no community-based studies on the association between frailty and risk of severe infection. Considering that different definitions have been identified to assess frailty, this study aimed to compare the association between frailty and severe COVID-19 infection in UK Biobank using two frailty classifications: the frailty phenotype and the frailty index.
Methods: A total of 383,845 UK Biobank participants recruited 2006-2010 in England (211,310 [55.1%] women, baseline age 37-73 years) were included. COVID-19 test data were provided by Public Health England (available up to 28 June 2020). An adapted version of the frailty phenotype derived by Fried et al. was used to define frailty phenotype (robust, pre-frail, or frail). A previously validated frailty index was derived from 49 self-reported questionnaire items related to health, disease and disability, and mental wellbeing (robust, mild frailty, and moderate/severe frailty). Both classifications were derived from baseline data (2006-2010). Poisson regression models with robust standard errors were used to analyse the associations between both frailty classifications and severe COVID-19 infection (resulting in hospital admission or death), adjusted for sociodemographic and lifestyle factors.
Results: Of UK Biobank participants included, 802 were admitted to hospital with and/or died from COVID19 (323 deaths and 479 hospitalisations). After analyses were adjusted for sociodemographic and lifestyle factors, a higher risk of COVID-19 was observed for pre-frail (risk ratio (RR) 1.47 [95% CI 1.26; 1.71]) and frail (RR 2.66 [95% CI 2.04; 3.47]) individuals compared to those classified as robust using the frailty phenotype. Similar results were observed when the frailty index was used (RR mildly frail 1.46 [95% CI 1.26; 1.71] and RR moderate/severe frailty 2.43 [95% CI 1.91; 3.10]).
Conclusions: Frailty was associated with a higher risk of severe COVID-19 infection resulting in hospital admission or death, irrespective of how it was measured and independent of sociodemographic and lifestyle factors. Public health strategies need to consider the additional risk that COVID-19 poses in individuals with frailty, including which additional preventive measures might be required.

Keywords: COVID-19; Coronavirus; Frailty; Risk factors.
 
Back
Top Bottom